Author

Mahboubeh Fereidan‐Esfahani

Observed name: Mahboubeh Fereidan-Esfahani

Institution: Mayo Clinic

Observed institutions: Dalhousie University, Mayo Clinic, Dell Children's Medical Center of Central Texas, The University of Texas at Austin

OpenAlex ID: A5070831716

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients

2023 · Mahboubeh Fereidan‐Esfahani, Paul A Decker, et al. · Annals of Clinical and Translational Neurology · 29

Population‐based incidence and clinico‐radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States

2021 · Mahboubeh Fereidan‐Esfahani, Paul A. Decker, et al. · European Journal of Neurology · 27

Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In Vitro

2020 · Mahboubeh Fereidan-Esfahani, Wei Ying Yue, et al. · Pharmaceuticals · 11

Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis

2023 · Caitlin S. Jackson-Tarlton, B. Mark Keegan, et al. · Multiple Sclerosis and Related Disorders · 6

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination

2026 · Fiorella S. Guido, John J. Chen, et al. · Journal of the Neurological Sciences · 1

Author response to letter

2026 · Fiorella S. Guido, John J. Chen, et al. · Journal of the Neurological Sciences

Deep Learning MRI Models for the Differential Diagnosis of Tumefactive Demyelination versusIDHWild-Type Glioblastoma

2025 · Gian Marco Conte, Mana Moassefi, et al. · American Journal of Neuroradiology

Nimg-26. Differentiation of Idh-wildtype Glioblastoma and Tumefactive Multiple Sclerosis Using Pre-operative Brain Mri and Deep Learning: Rigorous and Unbiased Experimental Design and Analytical Approach

2023 · Gian Marco Conte, Paul Decker, et al. · Neuro-Oncology

Works count: 8

Citation count: 74

H-index: 4

I10-index: 3